Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...

Germany's Merck KGaA is nearing a deal for SpringWorks Therapeutics, a source close to the deal said on Thursday. Shares of ...

Germany’s Merck KGaA is finally nearing a roughly $3.5 billion deal for SpringWorks Therapeutics, a U.S. biopharmaceutical ...

Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per ...

Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...

BURLINGTON, MA / ACCESS Newswire / April 24, 2025 / MilliporeSigma: Curiosity Cube tours North America, Europe, and for the ...

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Shares of SpringWorks Therapeutics climbed after The Wall Street Journal reported that Germany's Merck KGaA is nearing a $3.5 billion deal for the U.S. biopharmaceutical company. SpringWorks stock ...

This integration builds trust in AI systems regarding data authenticity and origin,” said Thomas Endress, Head of M-Trust™, Merck KGaA, Darmstadt, Germany. “Our collaboration with Zebra ...

Europe's souring business sentiment looks likely to put stocks on the defensive on Thursday, as President Donald Trump's ...

Merck will partner with Chinese biotech Abbisko ... expanding its commercialization rights for the drug beyond Asia. The German pharmaceutical company said Friday that it would pay Abbisko an ...

Deutsche Bank's Chief Investment Officer and chief strategist from private bank Merck Finck gives advice on how to protect ...